Activation of CD4 positive T cells is a primary requirement for human immunodeficiency virus (HIV) entry, efficient HIV replication, and progression to AIDS. Utilizing CD4 positive T cell lines and purified T cells from normal individuals, we have demonstrated that native envelope glycoproteins of HIV, gp160, can induce activation of transcription factor, activated protein-1 (AP-1). The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4-IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160. Immunoprecipitation of the gp160-induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP-1 complex is comprised of members of these family of proteins. The gp160-induced AP-1 complex is dependent upon protein tyrosine phosphorylation and is protein synthesis-independent. This stimulation can also be abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blocker or cyclosporine A. This gp160 treatment adversely affects the functional capabilities of T cells; pretreatment of CD4+ T cells with gp160 for 4 h at 37 °C inhibited anti-CD3-induced interleukin-2 secretion. Effects similar to gp160 were seen with anti-CD4 mAb. The aberrant activation of AP-1 by gp160 in CD4 positive T cells could result in up-regulation of cytokines containing AP-1 sites, e.g. interleukin-3 and granulocyte macrophage colony-stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin-2 secretion.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Rizzi, M. P. Crippa, R. E. Jeeninga, B. Berkhout, F. Blasi, G. Poli, and M. Alfano Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 1 J. Immunol., January 15, 2006; 176(2): 999 - 1006. [Abstract] [Full Text] [PDF]

				A. B. van 't Wout, G. K. Lehrman, S. A. Mikheeva, G. C. O'Keeffe, M. G. Katze, R. E. Bumgarner, G. K. Geiss, and J. I. Mullins Cellular Gene Expression upon Human Immunodeficiency Virus Type 1 Infection of CD4+-T-Cell Lines J. Virol., December 20, 2002; 77(2): 1392 - 1402. [Abstract] [Full Text] [PDF]

				Y.-M. Yang, W. C. Hatch, Z.-Y. Liu, B. Du, and J. E. Groopman {beta}-Chemokine Induction of Activation Protein-1 and Cyclic AMP Responsive Element Activation in Human Myeloid Cells Cell Growth Differ., April 1, 2001; 12(4): 211 - 221. [Abstract] [Full Text]

				T. H. Mogensen and S. R. Paludan Molecular Pathways in Virus-Induced Cytokine Production Microbiol. Mol. Biol. Rev., March 1, 2001; 65(1): 131 - 150. [Abstract] [Full Text] [PDF]

				A. A. Kapasi, S. Fan, and P. C. Singhal Role of 14-3-3{epsilon}, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation Am J Physiol Renal Physiol, February 1, 2001; 280(2): F333 - F342. [Abstract] [Full Text] [PDF]

				R. L. Hengel, B. M. Jones, M. S. Kennedy, M. R. Hubbard, and J. S. McDougal Markers of Lymphocyte Homing Distinguish CD4 T Cell Subsets That Turn Over in Response to HIV-1 Infection in Humans J. Immunol., September 15, 1999; 163(6): 3539 - 3548. [Abstract] [Full Text] [PDF]

				P. A. Klimiuk, J. J. Goronzy, and C. M. Weyand IL-16 as an Anti-Inflammatory Cytokine in Rheumatoid Synovitis J. Immunol., April 1, 1999; 162(7): 4293 - 4299. [Abstract] [Full Text] [PDF]

				W. Popik, J. E. Hesselgesser, and P. M. Pitha Binding of Human Immunodeficiency Virus Type 1 to CD4 and CXCR4 Receptors Differentially Regulates Expression of Inflammatory Genes and Activates the MEK/ERK Signaling Pathway J. Virol., August 1, 1998; 72(8): 6406 - 6413. [Abstract] [Full Text] [PDF]

				L. Briant, V. Robert-Hebmann, C. Acquaviva, A. Pelchen-Matthews, M. Marsh, and C. Devaux The Protein Tyrosine Kinase p56lck Is Required for Triggering NF-kappa B Activation upon Interaction of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 with Cell Surface CD4 J. Virol., July 1, 1998; 72(7): 6207 - 6214. [Abstract] [Full Text] [PDF]

				C. Guillerm, N. Coudronniere, V. Robert-Hebmann, and C. Devaux Delayed Human Immunodeficiency Virus Type 1-Induced Apoptosis in Cells Expressing Truncated Forms of CD4 J. Virol., March 1, 1998; 72(3): 1754 - 1761. [Abstract] [Full Text] [PDF]

				L. Briant, V. Robert-Hebmann, V. Sivan, A. Brunet, J. Pouyssegur, and C. Devaux Involvement of Extracellular Signal-Regulated Kinase Module in HIV-Mediated CD4 Signals Controlling Activation of Nuclear Factor-{kappa}B and AP-1 Transcription Factors J. Immunol., February 15, 1998; 160(4): 1875 - 1885. [Abstract] [Full Text] [PDF]

				S. M. L. Tamma, N. Chirmule, H. Yagura, N. Oyaizu, V. Kalyanaraman, and S. Pahwa CD4 Cross-Linking (CD4XL) Induces RAS Activation and Tumor Necrosis Factor-alpha Secretion in CD4+ T Cells Blood, August 15, 1997; 90(4): 1588 - 1593. [Abstract] [Full Text] [PDF]

				L. Briant, N. Signoret, M. Gaubin, V. Robert-Hebmann, X. Zhang, R. Murali, M. I. Greene, D. Piatier-Tonneau, and C. Devaux Transduction of Activation Signal That Follows HIV-1 Binding to CD4 and CD4 Dimerization Involves the Immunoglobulin CDR3-like Region in Domain 1 of CD4 J. Biol. Chem., August 1, 1997; 272(31): 19441 - 19450. [Abstract] [Full Text] [PDF]

				S. Bounou, N. Dumais, and M. J. Tremblay Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-kappa B- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription J. Biol. Chem., February 23, 2001; 276(9): 6359 - 6369. [Abstract] [Full Text] [PDF]